Skip to main content
. 2012 Aug 30;7(8):e44017. doi: 10.1371/journal.pone.0044017

Figure 3. Validation of A2BP1.

Figure 3

SZ39, SZ97 and iPSC-15 are iPSC lines developed using fibroblasts from patients with SZ.